AUTHORS
Meiting Liang, Yuping Gong Sr, MD2
AFFILIATIONS
1 Department of Hematology, West China Hospital, Sichuan University, Chengdu, China, Chengdu, China
2 Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
ABSTRACT
Background
Hereditary fibrinogen deficiency is a rare bleeding disorder caused by pathogenic variants in the FGA, FGB, or FGG genes, resulting in reduced fibrinogen levels and/or functional abnormalities. Large-scale, systematic studies characterizing the clinical and genetic features of this disorder in the Chinese population remain limited. This study aimed to investigate the clinical characteristics and genetic mutation spectrum of hereditary fibrinogen deficiency in a large cohort of Chinese patients.
Methods
A retrospective analysis was performed on 72 unrelated patients diagnosed with hereditary fibrinogen deficiency at West China Hospital, Sichuan University, between November 2018 and March 2026. Fibrinogen activity (FIB: C) was quantified using the Clauss method, and the ratio of Clauss FIB: C to PT-derived fibrinogen was calculated. Hypofibrinogenemia was defined as a Clauss/PT-derived fibrinogen ratio ≥ 0.47, and dysfibrinogenemia as a ratio < 0.47. All patients underwent targeted genetic testing, and clinical data, including bleeding and family history, were systematically collected.
Results
Of the 72 patients (22 males, 50 females; median age at diagnosis: 36.5 years), 64 had complete clinical documentation. The most common clinical presentations were incidental findings on routine laboratory testing (21/64, 32.8%), preoperative coagulation screening (16/64, 25.0%), bleeding manifestations (10/64, 15.6%), and pregnancy-related screening (10/64, 15.6%). Forty-six percent (26/64) of patients experienced at least one bleeding episode, with gingival bleeding and abnormal uterine bleeding the most prevalent. Patients with dysfibrinogenemia exhibited a significantly prolonged thrombin time compared with those with hypofibrinogenemia (30.9 ± 4.5 s vs. 25.0 ± 5.4 s, P < 0.001). Fibrinogen activity (FIB: C) showed a significant negative correlation with ISTH-BAT bleeding scores (r? = -0.264, P = 0.035). Genetic analysis identified 31 distinct pathogenic variants (12 novel), of which 22 (68.8%) were missense variants. The most common hotspot variants were FGA exon 2 c.104G>A (22 cases, 30.1%) and FGG exon 8 c.902G>A (15 cases, 20.5%), both detected exclusively in patients with dysfibrinogenemia. Nonsense variants (5.5%) were identified only in FGB and FGG and were associated with hypofibrinogenemia. Notably, FGB variants were exclusively found in patients with hypofibrinogenemia.
Conclusions
Genetic testing enables accurate subtyping and optimized family counseling/management of hereditary fibrinogen deficiency. Thrombin time may serve as a potential biomarker to distinguish qualitative from quantitative fibrinogen defects, particularly in resource-limited settings or large-scale screening programs.
DISCLOSURES
Meiting Liang: No relevant conflicts of interest to declare.